OP-2507

• UNSPSC Description:

  OP-2507 is a prostacyclin analog. OP-2507 can increase brain glucose levels in mice, suppress the breakdown of energy metabolism under hypoxic conditions, and has a protective effect against changes in cyclic nucleotides in hypoxic brain tissue (specifically, an increase in cyclic AMP and a decrease in cyclic GMP). OP-2507 provides protective effects against brain hypoxia and edema[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/op-2507.html

• Smiles:

  O=C(OC)CCCCC1=N[C@]2([H])[C@]([C@@H](/C=C/[C@@H](O)[C@H]3CC[C@@H](CCC)CC3)[C@H](O)C2)([H])C1

• Molecular Weight:

  419.60

• References & Citations:

  [1]Masuda Y, et al. Protective effect of a new prostacyclin analogue OP-2507 against cerebral anoxia and edema in experimental animals. Eur J Pharmacol. 1986 Apr 29;123(3):335-44.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  101758-79-6